<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2022.855122</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Multi-Modal Imaging in Neurological Conditions: Translational Applications</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Petracca</surname> <given-names>Maria</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/776264/overview"/>
</contrib>
</contrib-group>
<aff><institution>Department of Human Neurosciences, Sapienza University of Rome</institution>, <addr-line>Rome</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Jan Kassubek, University of Ulm, Germany</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Maria Petracca <email>maria&#x00040;petraccas.it</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Applied Neuroimaging, a section of the journal Frontiers in Neurology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>855122</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Petracca.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Petracca</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> 
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/14320/multi-modal-imaging-in-neurological-conditions-translational-applications" ext-link-type="uri">Editorial on the Research Topic <article-title>Multi-Modal Imaging in Neurological Conditions: Translational Applications</article-title></related-article> 
<kwd-group>
<kwd>multi-modal imaging</kwd>
<kwd>quantitative MRI</kwd>
<kwd>functional MRI</kwd>
<kwd>spectroscopy</kwd>
<kwd>fixel-based analysis</kwd>
<kwd>glutathione imaging</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="12"/>
<page-count count="3"/>
<word-count count="1577"/>
</counts>
</article-meta>
</front>
<body>
<p>Multi-modal imaging represents the ideal approach for the investigation of complex brain disorders. Thanks to the application of diverse imaging techniques and parameters, mechanisms sustaining disease development and progression can be evaluated from different points of view, gathering information on several aspects of brain structure and function (<xref ref-type="bibr" rid="B1">1</xref>). This approach offers the invaluable possibility to simultaneously assess abnormalities related to different pathophysiological pathways, characterize their interaction, and capture clinically meaningful features. Allowing for the rapid collection of a large amount of high-quality quantitative data, that can be used for the selection of relevant information, multi-modal imaging is to neuroscience what drone technology is to archeological site mapping. This Research Topic, hosting 3 review articles and 5 original articles, offers comprehensive overviews of multi-modal imaging applications, as well as experimental examples illustrating how multi-modal imaging can help us to (i) gain insight into the physiopathology of brain disorders and clinical deficits and (ii) identify biomarkers that might guide patient stratification for prognostic and therapeutic purposes.</p>
<p>The review article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2021.640239">Seiler et al.</ext-link> summarizes quantitative MRI findings in inflammatory, cerebrovascular and neurodegenerative disorders, highlighting the presence of similar pathological substrates across different, unrelated morbid conditions. Indeed, the determination of quantitative tissue parameters enables the detection of early abnormalities and the characterization of microstructural correlates of clinical manifestations. However, although of undisputable interest, the characterization of brain microstructure should always be interpreted after careful consideration of the intrinsic limitation of each method (<xref ref-type="bibr" rid="B2">2</xref>) and in light of the impact exerted by concomitant pathological processes, as, for example, in the case of atrophy and iron content/concentration (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>The second review, by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2021.632307">Sen et al.</ext-link> describes the pivotal role of multi-modality imaging in urea cycle disorders, focusing on MR spectroscopy and functional near infrared spectroscopy, which, assessing local changes in cerebral hemodynamic levels of cortical regions, represents a valuable surrogate to functional MRI (fMRI). The combination of spectroscopy and fMRI is particularly intriguing, as it allows to explore the relationship between neurotransmitter levels and cortical function (<xref ref-type="bibr" rid="B4">4</xref>). Finally, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2020.629463">Brown et al.</ext-link> focus on the clinical value and pathological meaning of multi-modal imaging, assessing improvements gained by utilizing a multi-modal approach in lieu of a single modality in Down&#x00027;s syndrome. Not only the Authors highlight the insights that might be gained through each method and their combination, but also discuss the relevance of ultra-high field MRI, whose application in clinical research has been a game changer for neuroimaging applications in epilepsy, brain tumors, dementia, neuro-psychiatric disorders, and multiple sclerosis (<xref ref-type="bibr" rid="B5">5</xref>). Indeed, the association of advanced imaging methods with ultra-high field MRI offers an invaluable tool to investigate disease pathophysiology, monitor disease progression, and treatment response (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>As per the investigation of structural modification behind clinical deficits, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2021.725059">Finkelstein et al.</ext-link> explored axonal degeneration in HIV patients at risk for neurocognitive impairment <italic>via</italic> fixel-based analysis, a recent diffusion-based technique that models individual fibers at the sub-voxel level. In this report, microstructural abnormalities in different white matter bundles are able to distinguish between cognitively normal patients and those with cognitive impairment, in line with the recently confirmed central role of white matter alterations in the pathogenesis of dementia (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>The investigation of neurocognitive impairment in HIV patients is also the aim of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2020.606592">Nguchu et al.</ext-link> which, exploring dynamic resting-state functional connectivity (FC), identified greater FC variability as a meaningful correlate of early cognitive impairment. Alterations in brain functional connectivity dynamics underlie cognitive impairment in different diseases (<xref ref-type="bibr" rid="B8">8</xref>), representing a perfect example of pathological mechanism translating across conditions. Finally, resting-state fMRI has also been applied by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2021.724874">Li et al.</ext-link> to characterize the functional circuits responsible for verbal fluency deficit in major depression.</p>
<p>Examples of how prognostic insights might be gained <italic>via</italic> multi-modal imaging are offered by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2020.590573">Andronesi et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2021.596294">Serlin et al.</ext-link> in two completely different settings.</p>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2020.590573">Andronesi et al.</ext-link> investigated the prognostic value of biochemical and structural imaging biomarkers, including glutathione imaging, in patients with amyotrophic lateral sclerosis (ALS), concluding that a multiparametric panel of diverse biomarkers might help to define a brain endophenotype, useful to stratify ALS patients into more homogeneous groups for therapeutic interventions compared to clinical criteria. The integration of multiple biomarkers, optimized by the application of machine learning approaches, has recently yield promising results for patients stratification and disease staging (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>On the other hand, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fneur.2021.596294">Serlin et al.</ext-link> propose optic nerve deformity as an auxiliary marker for neurological risk stratification in infants with enlarged CSF space in the context of benign external hydrocephalus. The search for easy-to-perform prognostic biomarkers is of significant importance, translating to different conditions and non-invasive methods (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Today, as exemplified by the works reported in this Research Topic, multi-modal imaging is still based on the combination of a limited number of parameters and techniques, as data acquisition and processing require the allocation of consistent resources in terms of funds, time, and specialized personnel. In the future, thanks to technical advancements and increasing availability of data through public repositories and sharing initiatives, we will be able to integrate information from an ever-growing number of sources, expanding the boundaries of multi-modal research beyond our current perspective.</p>
<sec id="s1">
<title>Author Contributions</title>
<p>The author confirms being the sole contributor of this work and has approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s2">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec> 
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inglese</surname> <given-names>M</given-names></name> <name><surname>Petracca</surname> <given-names>M</given-names></name></person-group>. <article-title>Imaging multiple sclerosis and other neurodegenerative diseases</article-title>. <source>Prion.</source> (<year>2013</year>) <volume>7</volume>:<fpage>47</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.4161/pri.22650</pub-id><pub-id pub-id-type="pmid">23117868</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schilling</surname> <given-names>KG</given-names></name> <name><surname>Rheault</surname> <given-names>F</given-names></name> <name><surname>Petit</surname> <given-names>L</given-names></name> <name><surname>Hansen</surname> <given-names>CB</given-names></name> <name><surname>Nath</surname> <given-names>V</given-names></name> <name><surname>Yeh</surname> <given-names>FC</given-names></name> <etal/></person-group>. <article-title>Tractography dissection variability: what happens when 42 groups dissect 14 white matter bundles on the same dataset?</article-title> <source>Neuroimage.</source> (<year>2021</year>) <volume>243</volume>:<fpage>118502</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2021.118502</pub-id><pub-id pub-id-type="pmid">34433094</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pontillo</surname> <given-names>G</given-names></name> <name><surname>Petracca</surname> <given-names>M</given-names></name> <name><surname>Monti</surname> <given-names>S</given-names></name> <name><surname>Quarantelli</surname> <given-names>M</given-names></name> <name><surname>Criscuolo</surname> <given-names>C</given-names></name> <name><surname>Lanzillo</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Unraveling deep gray matter atrophy and iron and myelin changes in multiple sclerosis</article-title>. <source>Am J Neuroradiol.</source> (<year>2021</year>) <volume>42</volume>:<fpage>1223</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A7093</pub-id><pub-id pub-id-type="pmid">33888456</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Droby</surname> <given-names>A</given-names></name> <name><surname>Fleysher</surname> <given-names>L</given-names></name> <name><surname>Petracca</surname> <given-names>M</given-names></name> <name><surname>Podranski</surname> <given-names>K</given-names></name> <name><surname>Xu</surname> <given-names>J</given-names></name> <name><surname>Fabian</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Lower cortical gamma-aminobutyric acid level contributes to connectivity in sensory-motor inter-connected regions in progressive MS</article-title>. <source>Mult Scler Relat Disord.</source> (<year>2020</year>) <volume>43</volume>:<fpage>102183</fpage>. <pub-id pub-id-type="doi">10.1016/j.msard.2020.102183</pub-id><pub-id pub-id-type="pmid">32480344</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barisano</surname> <given-names>G</given-names></name> <name><surname>Sepehrband</surname> <given-names>F</given-names></name> <name><surname>Ma</surname> <given-names>S</given-names></name> <name><surname>Jann</surname> <given-names>K</given-names></name> <name><surname>Cabeen</surname> <given-names>R</given-names></name> <name><surname>Wang</surname> <given-names>DJ</given-names></name> <etal/></person-group>. <article-title>Clinical 7 t MRi: are we there yet? A review about magnetic resonance imaging at ultra-high field</article-title>. <source>Br J Radiol.</source> (<year>2019</year>) <volume>92</volume>:<fpage>20180492</fpage>. <pub-id pub-id-type="doi">10.1259/bjr.20180492</pub-id><pub-id pub-id-type="pmid">30359093</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schiavi</surname> <given-names>S</given-names></name> <name><surname>Petracca</surname> <given-names>M</given-names></name> <name><surname>Sun</surname> <given-names>P</given-names></name> <name><surname>Fleysher</surname> <given-names>L</given-names></name> <name><surname>Cocozza</surname> <given-names>S</given-names></name> <name><surname>El Mendili</surname> <given-names>MM</given-names></name> <etal/></person-group>. <article-title>Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis</article-title>. <source>Brain.</source> (<year>2021</year>) <volume>144</volume>:<fpage>213</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awaa381</pub-id><pub-id pub-id-type="pmid">33253366</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Egle</surname> <given-names>M</given-names></name> <name><surname>Hilal</surname> <given-names>S</given-names></name> <name><surname>Tuladhar</surname> <given-names>AM</given-names></name> <name><surname>Pirpamer</surname> <given-names>L</given-names></name> <name><surname>Hofer</surname> <given-names>E</given-names></name> <name><surname>Duering</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Prediction of dementia using diffusion tensor MRI measures: the OPTIMAL collaboration</article-title>. <source>J Neurol Neurosurg Psychiatry.</source> (<year>2022</year>) <volume>93</volume>:<fpage>14</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2021-326571</pub-id><pub-id pub-id-type="pmid">34509999</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>Z</given-names></name> <name><surname>Caprihan</surname> <given-names>A</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Du</surname> <given-names>Y</given-names></name> <name><surname>Adair</surname> <given-names>JC</given-names></name> <name><surname>Sui</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Altered static and dynamic functional network connectivity in Alzheimer&#x00027;s disease and subcortical ischemic vascular disease: shared and specific brain connectivity abnormalities</article-title>. <source>Hum Brain Mapp.</source> (<year>2019</year>) <volume>40</volume>:<fpage>3203</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.24591</pub-id><pub-id pub-id-type="pmid">30950567</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tommasin</surname> <given-names>S</given-names></name> <name><surname>Cocozza</surname> <given-names>S</given-names></name> <name><surname>Taloni</surname> <given-names>A</given-names></name> <name><surname>Giann&#x000EC;</surname> <given-names>C</given-names></name> <name><surname>Petsas</surname> <given-names>N</given-names></name> <name><surname>Pontillo</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Machine learning classifier to identify clinical and radiological features relevant to disease progression in multiple sclerosis</article-title>. <source>J Neurol.</source> (<year>2021</year>) <volume>268</volume>:<fpage>4834</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-021-10605-7</pub-id><pub-id pub-id-type="pmid">33970338</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>AL</given-names></name> <name><surname>Oxtoby</surname> <given-names>NP</given-names></name> <name><surname>Daga</surname> <given-names>P</given-names></name> <name><surname>Cash</surname> <given-names>DM</given-names></name> <name><surname>Fox</surname> <given-names>NC</given-names></name> <name><surname>Ourselin</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>A data-driven model of biomarker changes in sporadic Alzheimer&#x00027;s disease</article-title>. <source>Brain.</source> (<year>2014</year>) <volume>137</volume>:<fpage>2564</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awu176</pub-id><pub-id pub-id-type="pmid">25012224</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pontillo</surname> <given-names>G</given-names></name> <name><surname>Cocozza</surname> <given-names>S</given-names></name> <name><surname>Di Stasi</surname> <given-names>M</given-names></name> <name><surname>Carotenuto</surname> <given-names>A</given-names></name> <name><surname>Paolella</surname> <given-names>C</given-names></name> <name><surname>Cipullo</surname> <given-names>MB</given-names></name> <etal/></person-group>. <article-title>2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis</article-title>. <source>Eur Radiol.</source> (<year>2020</year>) <volume>30</volume>:<fpage>3813</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/s00330-020-06738-4</pub-id><pub-id pub-id-type="pmid">32100089</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>WC</given-names></name> <name><surname>Tao</surname> <given-names>JX</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name></person-group>. <article-title>Optical coherence tomography measurements as potential imaging biomarkers for Parkinson&#x00027;s disease: a systematic review and meta-analysis</article-title>. <source>Eur J Neurol.</source> (<year>2021</year>) <volume>28</volume>:<fpage>763</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1111/ene.14613</pub-id><pub-id pub-id-type="pmid">33107159</pub-id></citation></ref>
</ref-list> 
</back>
</article> 